Centrum für Integrierte Onkologie

Recent papers from Centrum für Integrierte Onkologie

1. Identification and relevance of inter‐tumour heterogeneity in hepatocellular adenoma according to subtypes and the contextHistopathology · 2026
2. Truncal blocks in ambulatory surgery: what is the evidence?Current Opinion in Anaesthesiology · 2026
3. Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe : A cross‐sectional analysis of the HDV‐Europe cohortHIV Medicine · 2026
4. Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant HypertensionJournal of the American College of Cardiology · 2011
5. A Multiphase Combined Treatment Including Individualized Multimodal Immunotherapy and Tumor Microenvironment Therapy for Glioblastoma: A Decade of Experience with Real-World PatientsBiomedicines · 2026
6. Allogeneic stem cell transplantation after myeloablative conditioning with fludarabine, thiotepa, and cyclophosphamide in relapsed or refractory aggressive B-cell and T-cell lymphomas: results of the prospective ASTRAL studyHaematologica · 2026
7. One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up StudyCirculation Cardiovascular Interventions · 2026
8. Factors associated with successful psychiatric intensive home treatment – a quasi-experimental studyFrontiers in Psychiatry · 2026
9. BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, abnormal muscle tone and movement abnormalitiesJournal of Medical Genetics · 2026
10. Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaBlood Advances · 2026
11. AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 UpdateThe Breast · 2026
12. Variations in Surgical Strategies and Treatment Allocation for Retroperitoneal Sarcomas Across German-Speaking Sarcoma CentresEuropean Journal of Surgical Oncology · 2026
13. Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centeredClinical and Translational Radiation Oncology · 2026
14. A phase 1 study of the PRMT5 inhibitor AZD3470 in patients with relapsed/refractory classic Hodgkin lymphoma (PRIMAVERA).Journal of Clinical Oncology · 2026
15. AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026European Journal of Surgical Oncology · 2026
16. Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identificationVirchows Archiv · 2026
17. Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialJournal of Clinical Oncology · 2026
18. Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 AnalysisThe Oncologist · 2026
19. Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancernpj Breast Cancer · 2026
20. Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesBlood Advances · 2026